Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context

Laura Chiecchio, Gian Paolo Dagrada, Ashraf H. Ibrahim, Elizabet Dachs Cabanas, Rebecca K M Protheroe, David M. Stockley, Kim H. Orchard, Nicholas C P Cross, Christine J. Harrison, Fiona M. Ross

Research output: Contribution to journalArticle

Abstract

Background: Multiple myeloma, monoclonal gammopathy of undetermined significance and smoldering multiple myeloma harbor common chromosomal abnormalities but the prevalence and relative association of aberrations in these diagnostic groups remains controversial. We investigated these aspects in a large series of patients. Design and Methods: Chromosome 13 deletion (D13), deletion of TP53, ploidy status and immunoglobulin heavy chain (IgH) translocations were evaluated by fluorescence in situ hybridization in patients with monoclonal gammopathy of undetermined significance (n=189), smoldering multiple myeloma (n=127) and multiple myeloma (n=400). Results: Overall, Δ13 (25%, 34% and 47%), 16q23 deletions (6%, 8% and 21%) and 17p13 deletions (3%, 1% and 10%) were less frequent in patients with monoclonal gammopathy of undetermined significance and smoldering multiple myeloma than in those with multiple myeloma. When distinct genetic groups were considered, no differences in the prevalence of Δ13 were found with t(4;14)(p16;q32) and t(14;16)(q32;q23) among the three diagnostic groups; in contrast Δ13 was rarer in t(11;14)(q13;q32) in patients with monoclonal gammopathy (1/28) and smoldering myeloma (2/13) than in those with multiple myeloma (40%). Similar results were seen for the few t(6;14)(p21;q32) cases: 0/3 patients with monoclonal gammopathy or smoldering myeloma had the Δ13, whereas 4/6 (67%) patients with multiple myeloma and this translocation also had the deletion. In multiple myeloma patients with both an IgH translocation and Δ13, the proportions of cells affected by the two abnormalities were similar, as was the case for t(4;14) and t(14;16) monoclonal gammopathy patients positive for Δ13. In contrast, in monoclonal gammopathy patients with t(14;20)(q32;q11), the translocation was present in almost all cells, while the Δ13 was present in only a sub-population. Conclusions: These results indicate that the presence and time of occurrence of Δ13 depends on the presence of specific concurrent abnormalities. The observation that Δ13 was extremely rare in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma with translocations directly involving cyclin D genes (CCND1 and CCND3) suggest a possible role of Δ13 in the progression of the disease specifically in these genetic sub-groups.

Original languageEnglish
Pages (from-to)1708-1713
Number of pages6
JournalHaematologica
Volume94
Issue number12
DOIs
Publication statusPublished - Dec 2009

Keywords

  • Deletion 13
  • Genetic context
  • Plasma cell dyscrasias

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context'. Together they form a unique fingerprint.

  • Cite this

    Chiecchio, L., Dagrada, G. P., Ibrahim, A. H., Cabanas, E. D., Protheroe, R. K. M., Stockley, D. M., Orchard, K. H., Cross, N. C. P., Harrison, C. J., & Ross, F. M. (2009). Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context. Haematologica, 94(12), 1708-1713. https://doi.org/10.3324/haematol.2009.011064